β-Endorphin Mediates Electroacupuncture-Induced Remyelination via Neural Stem Cell Lineage Modulation in Experimental Autoimmune Encephalomyelitis.

Researchers studying multiple sclerosis (MS) have discovered how electroacupuncture may help repair the protective coating around nerve fibers, a process called remyelination. MS damages this myelin coating, leading to nerve signal problems and disability. In this animal study using mice with a condition similar to MS, scientists applied electroacupuncture daily to the Zusanli point (ST36) on the leg. They found that electroacupuncture stimulated the body to produce more beta-endorphin, a natural pain-relieving chemical made in the brain. This beta-endorphin triggered stem cells in the brain to multiply and develop into the specific cells needed to rebuild myelin. The treatment improved disease symptoms, reduced nerve damage, and decreased inflammation in the nervous system. When researchers blocked the opioid receptors that beta-endorphin normally activates, these beneficial effects disappeared, confirming that electroacupuncture works through this natural opioid pathway. The findings suggest electroacupuncture doesn't just manage MS symptoms but may actually help repair nerve damage by awakening the body's own regenerative processes. While this research used an animal model and human studies are needed, it provides scientific evidence for a mechanism by which acupuncture could support nerve healing in demyelinating diseases. The study focused on electroacupuncture, which adds mild electrical stimulation to traditional needle insertion. If you're considering acupuncture for MS or related conditions, seek a licensed acupuncturist with experience treating neurological conditions.

This study investigated electroacupuncture's remyelination effects in experimental autoimmune encephalomyelitis (EAE) mice, an established MS model. Daily EA at ST36 significantly enhanced neural stem cell (NSC) proliferation and oligodendrocyte progenitor cell (OPC) differentiation in the subventricular zone. Treatment improved clinical scores, reduced demyelination, and decreased CNS leukocyte infiltration. Mechanistically, EA upregulated β-endorphin, its precursor POMC, and opioid receptors (MOR/KOR encoded by Oprm1/Oprk1) in hypothalamus and SVZ. Administration of naloxone, a nonselective opioid antagonist, completely abolished EA's beneficial effects on NSC behavior and remyelination, confirming opioid receptor-dependent β-EP signaling as the primary mechanism. Assessment methods included immunofluorescence, flow cytometry, and RT-qPCR. Findings reveal EA promotes neuroregenerative processes beyond symptomatic relief, supporting its potential as adjunctive therapy for demyelinating diseases. The β-endorphin-opioid receptor pathway represents a novel mechanism linking acupuncture stimulation to endogenous stem cell activation and myelin repair.